This bill establishes safety and regulatory requirements for compounded medications in Washington State, emphasizing the importance of using reputable and inspected sources for active pharmaceutical ingredients. It outlines specific conditions under which compounded drugs can be sold, including compliance with United States pharmacopoeia standards, verification of pharmaceutical-grade products, and the necessity of maintaining detailed records related to the bulk drug substances used. The bill also grants the commission authority to inspect entities involved in compounding drugs and imposes penalties for violations, including fines and potential revocation of pharmacy licenses.

Additionally, the bill includes provisions to ensure that any conflicting parts with federal requirements will be rendered inoperative only to the extent of the conflict, while still allowing the remainder of the act to function. The act is deemed necessary for the immediate preservation of public health and safety, and it takes effect immediately upon passage.